BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12715435)

  • 1. [Hydronephrosis as a prognostic factor for patients of figo IIIB cervical cancer].
    Krynicki R; Bidziński M; Wierzba W; Panek G; Jońska J; Lindner B
    Ginekol Pol; 2003 Jan; 74(1):32-9. PubMed ID: 12715435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens.
    Mayer A; Nemeskéri C; Petneházi C; Borgulya G; Varga S; Naszály A
    Strahlenther Onkol; 2004 Apr; 180(4):209-15. PubMed ID: 15057431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.
    Tan LT; Jones B; Gee A; Kingston RE
    Br J Radiol; 1997 Dec; 70(840):1259-69. PubMed ID: 9505845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences.
    Sorbe B; Bohr L; Karlsson L; Bermark B
    Int J Oncol; 2010 Feb; 36(2):371-8. PubMed ID: 20043071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor heterogeneity of FIGO stage III carcinoma of the uterine cervix.
    Kim YB; Lee IJ; Kim SY; Kim JW; Yoon HI; Kim SW; Kim S; Kim YT; Suh CO; Kim GE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1323-8. PubMed ID: 19467800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of tumor diameter on treatment results in cervical cancer patients].
    Jońska-Gmyrek J; Zółciak-Siwińska A; Gmyrek L; Staniaszek J; Lindner B; Andrzejuk J
    Ginekol Pol; 2012 Aug; 83(8):576-80. PubMed ID: 23342879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
    Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
    BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: a multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 (study of JASTRO 2006-2007).
    Niibe Y; Kenjo M; Onishi H; Ogawa Y; Kazumoto T; Ogino I; Tsujino K; Harima Y; Takahashi T; Anbai A; Tsuchida E; Toita T; Takemoto M; Yamashita H; Hayakawa K
    Jpn J Clin Oncol; 2010 Aug; 40(8):795-9. PubMed ID: 20444747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gynecologic Oncology Group study.
    Rose PG; Ali S; Whitney CW; Lanciano R; Stehman FB
    Gynecol Oncol; 2010 May; 117(2):270-5. PubMed ID: 20181381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heuristically derived tumor burden score as a prognostic factor for stage IIIB carcinoma of the cervix.
    Arthur D; Kaufman N; Schmidt-Ullrich R; Kavanagh B; Simpson P; Hill M; Ali M
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):743-51. PubMed ID: 7860385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of high-dose-rate brachytherapy of the preoperative treatment of stage IB (FIGO) cervical carcinoma].
    Mayer A; Nemeskéri C; Póti Z
    Magy Onkol; 2004; 48(2):141-4. PubMed ID: 15351809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different prognosis of stage IIIB cervical cancer patients with lower third of vaginal invasion and those without.
    Fang C; Zhang P; Yu A; Yang Y; Zhang J
    Gynecol Oncol; 2021 Jul; 162(1):50-55. PubMed ID: 33858676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
    Tacev T; Vacek A; Ptácková B; Strnad V
    Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma.
    Kapp KS; Poschauko J; Tauss J; Berghold A; Oechs A; Lahousen M; Petru E; Winter R; Kapp DS
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1399-404. PubMed ID: 16029799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical results of medium dose rate brachytherapy combined with external beam radiotherapy in the treatment of advanced cervical carcinoma.
    Ordeanu C; Coza O; Gavris S; Todor N; Szilagy E; Bako M; Cernea V; Ghilezan N; Nagy V
    J BUON; 2007; 12(2):221-6. PubMed ID: 17600876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up results of irradiation alone or combined with surgery in stage I-IV carcinoma of the uterine cervix.
    Reinartz G; Bartsch S; Willich N
    Zentralbl Gynakol; 2000; 122(6):318-23. PubMed ID: 10904995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma.
    Muschitz S; Petrow P; Briot E; Petit C; De Crevoisier R; Duvillard P; Morice P; Haie-Meder C
    Radiother Oncol; 2004 Nov; 73(2):187-94. PubMed ID: 15542166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Californium-252 brachytherapy combined with external-beam radiotherapy for cervical cancer: long-term treatment results.
    Lei X; Qian CY; Qing Y; Zhao KW; Yang ZZ; Dai N; Zhong ZY; Tang C; Li Z; Gu XQ; Zhou Q; Feng Y; Xiong YL; Shan JL; Wang D
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1264-70. PubMed ID: 21435797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.